Positive and negative symptoms in schizophrenia. A critical reappraisal.
about
Avolition and expressive deficits capture negative symptom phenomenology: implications for DSM-5 and schizophrenia research.Phospholipase C-β1 Hypofunction in the Pathogenesis of Schizophrenia.DUF1220 copy number is associated with schizophrenia risk and severity: implications for understanding autism and schizophrenia as related diseasesNegative symptoms and visual behavior in DSM-III-R prognostic subtypes of schizophreniform disorderPsychotic-Like Experiences at the Healthy End of the Psychosis Continuum.[Frontal lobe hypoactivity in schizophrenia: change in perspective]Negative symptoms and concomitant attention deficits in schizophrenia: associations with prospective assessments of anxiety, social dysfunction, and avoidant coping.Negative symptoms in nondeficit syndrome respond to neuroleptic treatment with changes in plasma homovanillic acid concentrations.Longitudinal treatment outcome of African American and Caucasian patients with first episode psychosisThe influence of illness duration on syndrome clarity and stability in functional psychosis: does the diagnosis emerge and stabilise with time?The neurochemistry of waking and sleeping mental activity: the disinhibition-dopamine hypothesis.The FOCUS trial: cognitive remediation plus standard treatment versus standard treatment for patients at ultra-high risk for psychosis: study protocol for a randomised controlled trialNeuropsychological evidence supporting a neurodevelopmental model of schizophrenia: a longitudinal study.Effects of gastrodia elata bl on phencyclidine-induced schizophrenia-like psychosis in mice.Handling diagnosis of schizophrenia by a hybrid method.Ten-year follow-up of the OPUS specialized early intervention trial for patients with a first episode of psychosis.Relationship of neurocognitive deficits to diagnosis and symptoms across affective and non-affective psychoses.Cognitive alterations as markers of vulnerability to schizophrenia.Pharmacogenetic studies of response to risperidone and other newer atypical antipsychotics.Schizophrenia-relevant behavioral testing in rodent models: a uniquely human disorder?Chronic smoking and the BOLD response to a visual activation task and a breath hold task in patients with schizophrenia and healthy controls.A Role for the Transcription Factor Nk2 Homeobox 1 in Schizophrenia: Convergent Evidence from Animal and Human StudiesSubtyping first-episode non-affective psychosis using four early-course features: potentially useful prognostic information at initial presentationPerinatal complications and schizophrenia: involvement of the immune system.Longitudinal progression of negative symptoms in schizophrenia: a new look at an old problem.Negative symptoms, defect state and Huber's basic symptoms: a comparison of the concepts.Psychiatric comorbidity among adults with schizophrenia: a latent class analysisHIV Risk Behavior among Outpatients at a State Psychiatric Hospital: Prevalence and Risk ModelingCognitive factors for predicting treatment response in schizophrenic patients: one-year follow-up study.Evolution of neuropsychological dysfunction during the course of schizophrenia and bipolar disorder.The influence of neurocognitive dysfunctions on work capacity in schizophrenia patients: a systematic review of the literature.Discovery of novel N-substituted oxindoles as selective m1 and m4 muscarinic acetylcholine receptors partial agonists.Lack of association between AKT1 variances versus clinical manifestations and social function in patients with schizophrenia.Medical disorders in the schizophrenic patient.What do we really know about late-onset schizophrenia?TAILOR - tapered discontinuation versus maintenance therapy of antipsychotic medication in patients with newly diagnosed schizophrenia or persistent delusional disorder in remission of psychotic symptoms: study protocol for a randomized clinical triThe stability of symptoms and syndromes in chronic schizophrenic patients.Object relations deficits in subtypes of schizophrenia.Functional motor asymmetries correlated with clinical findings in unmedicated schizophrenic patients.Predictors of remission and recovery in a first-episode schizophrenia spectrum disorder sample: 2-year follow-up of the OPUS trial.
P2860
Q24630535-1F4B923D-6102-4DF0-BBD1-FB7AB4208D27Q26774767-BACE2F87-C53A-4102-8564-11B70B02BEE6Q28271073-315D4D4E-6CAB-4BA5-926D-787359E7572CQ28282970-D4BC1EB4-FE03-451D-A417-48E5096628D3Q30376851-63E27BC0-3616-415E-8DDC-B7F0071FBBADQ30901421-89926E33-0B2F-4FA5-B462-73DCC9AF62ACQ33831204-6C132FB1-2BEC-4AC2-B7D1-D68C7F343794Q33921723-F7AD4ED7-98FC-487C-9FDE-C347B461A853Q34285071-43CB2B68-1B19-4FB2-820A-10E572534A93Q34314122-B03EA5D1-29D2-4609-A002-695FC6846DDFQ34730873-D22E5CFD-B7C3-42BD-A77E-22468764F2C0Q35052697-3A6CCF45-0F64-473D-AA2D-D439723F7B62Q35101090-1597B3C6-C53B-4FBD-9424-01AC1F02FE20Q35107849-CD36A7C1-E4BC-431A-A3C7-08C89C246D70Q35188202-99EDA4E9-E876-4514-A786-EAF804D5354CQ35369834-B3476C05-0397-4692-B072-C85F9DD6F604Q35577541-73B2CD3B-0B69-4148-97E3-6EE7FF00581EQ35670908-99FA12C8-5401-4D44-B103-E92AB689FB85Q36120821-EF805FB9-77F7-456D-8529-1944E26F666CQ36517227-D03CDC9C-A6D0-47E0-B6B4-23EB708E0803Q36559599-4A3E06FC-4116-4A24-A89A-A67766518E5EQ36740391-3294BCA2-2EB5-4B2A-851F-5FF91AA6ED63Q36902097-B5E21BB8-9B39-474A-ACE5-10C1C8B1C44AQ36952179-F338C293-E4EA-4771-80D8-B22EAAF522BFQ37010792-B805B079-FF2E-41A6-832D-268CF5A70BD4Q37039975-F35A1A46-5BE9-41C7-9916-9D4CD9030F5BQ37239425-DE244480-92E7-4941-A427-29B4A0A9B405Q37269794-9D133F08-1E58-4DFB-B244-34BEE15B6119Q37483935-F57B6739-BCEB-4698-9EF4-2F2902034A70Q37788304-EC2220F7-6E22-431A-B896-4AC2F11129ACQ38220918-DF1525A8-912D-4726-9AC2-52155EEC2B08Q39778911-9B528987-AE15-4C0F-A770-568D23F05A27Q40069536-04B66A88-4FF8-40AB-9CB2-01801C516947Q40433554-28872B4E-92C4-41FA-9626-6F0C4C6B3472Q41614039-0A57EBCC-2722-4A9A-B721-3480EF153EEFQ42031334-9F3BB63F-EF80-4085-B057-CC99FFE232C4Q42156649-13A29E48-438A-4427-BF64-9844BF1E8933Q43723441-3B55E484-1CBB-481F-98F7-04A4591F941FQ43739616-F8493297-33CC-4FF3-8E26-FA5B075B8606Q44221972-4BA90EF7-438D-4807-811B-FD2BE1C0550B
P2860
Positive and negative symptoms in schizophrenia. A critical reappraisal.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh-hant
name
Positive and negative symptoms in schizophrenia. A critical reappraisal.
@en
Positive and negative symptoms in schizophrenia. A critical reappraisal.
@nl
type
label
Positive and negative symptoms in schizophrenia. A critical reappraisal.
@en
Positive and negative symptoms in schizophrenia. A critical reappraisal.
@nl
prefLabel
Positive and negative symptoms in schizophrenia. A critical reappraisal.
@en
Positive and negative symptoms in schizophrenia. A critical reappraisal.
@nl
P2093
P1433
P1476
Positive and negative symptoms in schizophrenia. A critical reappraisal.
@en
P2093
P304
P356
10.1001/ARCHPSYC.1990.01810190015002
P407
P577
1990-07-01T00:00:00Z